Last updated on February 2018

Umbilical Cord Blood Transplantation From Unrelated Donors


Brief description of study

This study is a single-center, treatment protocol with 4 possible preparative regimens, designed to validate the process of umbilical cord blood stem cell transplantation at our institution.

Detailed Study Description

This study is a single-center treatment protocol with four possible preparative regimens, designed to validate the process of umbilical cord blood stem cell transplantation at our institution. Enrolled patients will receive chemotherapy +/-total body radiation as a pre-transplant conditioning regimen. Patients will then receive cord blood stem cells followed by GvHD prophylaxis that will include Tacrolimus and Mycophenolate Mofetil, or Cyclosporin A and Methylprednisolone. Multiple data points will be collected prior to, during, and following transplantation to ensure safety of the process and to evaluate the stated objectives.

Clinical Study Identifier: NCT03016806

Contact Investigators or Research Sites near you

Start Over

Jane L Liesveld, MD

Wilmot Cancer Institute
Rochester, NY United States
  Connect »